0.0001USD0.00%Mkt Cap: 3073 USDP/E: —Last update: 2026-05-22
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is desi…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap3.07K USD
Enterprise Value3.12M USD
Revenue (TTM)1.00M USD
Gross Profit422.71K USD
Net Income (TTM)-18.00M USD
Revenue/Share0.0510 USD
Last Price0.0001 USD
Fiscal Year EndDec 2022
MR QuarterSep 2023
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.41
EV/Revenue3.12
P/S0.00
P/B-0.00
EPS (TTM)-0.22
EPS (Forward)—
52W Range
0.00010% of range0.0002
52W High0.0002 USD
52W Low0.0001 USD
Profitability
Gross Margin66.77%
Oper. Margin-1582.47%
EBITDA Margin0.00%
Profit Margin-2843.79%
ROE288.20%
ROA-483.06%
Growth
Revenue Growth-42.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.77M USD
CapEx (TTM)28.61K USD
FCF Margin-298.77%
FCF Yield-97262.19%
Net Debt-1.21M USD
Net Debt/EBITDA0.16
Balance Sheet
Debt/Equity-0.05
Current Ratio0.90
Quick Ratio0.64
Book Value/Sh-0.1370 USD
Cash/Share0.0580 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.30.74M
Float13.53M
Insiders62.18%
Institutions0.00%
Short Interest
Short Ratio0.8d
Short % Float1.36%
Short % Out.0.92%
Shares Short281.55K
Short (prev mo.)27.93K
Technical
SMA 500.0001 (-0.0%)
SMA 2000.0001 (-12.7%)
Beta-70.97
S&P 52W Chg28.31%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—